These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16009055)

  • 1. Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis.
    Sellebjerg F
    Dan Med Bull; 2004 May; 51(2):167-83. PubMed ID: 16009055
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept induced multiple sclerosis and transverse myelitis.
    Al Saieg N; Luzar MJ
    J Rheumatol; 2006 Jun; 33(6):1202-4. PubMed ID: 16755671
    [No Abstract]   [Full Text] [Related]  

  • 3. [Promising results with methylprednisolone in multiple sclerosis. Lack of patent rights makes drug industry less interested].
    Kling A; Dahlqvist R
    Lakartidningen; 2007 Jan 17-23; 104(3):128-30. PubMed ID: 17302117
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid].
    Hrazdira CL; Mandzjuk B; Skálová M
    Cesk Neurol Neurochir; 1974 Sep; 37(5):293-300. PubMed ID: 4479029
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent headache due to MS plaque.
    Alstadhaug K; Breivik K; Rusic Z
    Headache; 2008 Mar; 48(3):453-4. PubMed ID: 18081822
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?
    Chataway J
    Mult Scler; 2014 May; 20(6):643-5. PubMed ID: 24756993
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    Reinhardt C; Reul JM; Melms A
    Lancet; 1997 Jun; 349(9066):1697-8. PubMed ID: 9186401
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis.
    Sellebjerg F; Christiansen M; Jensen J; Frederiksen JL
    Eur J Neurol; 2000 May; 7(3):281-9. PubMed ID: 10886311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral or intravenous methylprednisolone for acute relapses of MS?
    Barkhof F; Polman C
    Lancet; 1997 Mar; 349(9056):893-4. PubMed ID: 9093245
    [No Abstract]   [Full Text] [Related]  

  • 10. Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study.
    Vercellino M; Votta B; Condello C; Piacentino C; Romagnolo A; Merola A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuroimmunol; 2008 Aug; 199(1-2):133-41. PubMed ID: 18539342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulse therapy in the treatment of optic neuritis in multiple sclerosis].
    Neroev VV; Karlova IZ; Guseva MR; Zaĭtseva OV; Boĭko SIu; Sidorenko EI; Dubovskaia LA; Budzinskaia MV; Boĭko AN
    Vestn Oftalmol; 2003; 119(5):28-31. PubMed ID: 14598491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy.
    Navarro J; Aristimuño C; Sánchez-Ramón S; Vigil D; Martínez-Ginés ML; Fernández-Cruz E; de Andrés C
    J Neuroimmunol; 2006 Jul; 176(1-2):153-61. PubMed ID: 16698092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
    Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
    Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination.
    Vrethem M; Malmgren K; Lindh J
    J Neurol Sci; 2012 Oct; 321(1-2):89-91. PubMed ID: 22841884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].
    Jedlicka P; Kupka J; Kocinová F
    Cesk Neurol Neurochir; 1975 Dec; 38(6):338-45. PubMed ID: 1104205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myelin basic protein stimulation index of CD 2 cells in the course of steroid treatment].
    Wender M; Sniatała-Kamasa M; Wójcicka M; Tokarz-Kupczyk E; Losy J
    Neurol Neurochir Pol; 1999; 33(4):765-70. PubMed ID: 10612091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of glucocorticoids on neuropathic pain: a review with emphasis on intrathecal methylprednisolone acetate delivery.
    Rijsdijk M; van Wijck AJ; Kalkman CJ; Yaksh TL
    Anesth Analg; 2014 May; 118(5):1097-112. PubMed ID: 24781577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANA negative SLE male patient with predominant pulmonary involvement.
    Shaikh YA
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):239. PubMed ID: 16542614
    [No Abstract]   [Full Text] [Related]  

  • 20. [Corticosteroids in the treatment of multiple sclerosis and optic neuritis].
    Elovaara I; Pirttilä T
    Duodecim; 2000; 116(15):1547-54. PubMed ID: 12001474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.